July 31st 2025
Taletrectinib was added to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology as a preferred option for the first-line and subsequent treatment of advanced ROS1-positive non–small cell lung cancer (NSCLC).
The authors interrogate elements of routine medical practice in New York City to argue for reforms of hospital culture through relational trust-building capabilities of community health workers.
Read More
Community-Based Cycling Program Shows Positive Impact on Symptom Management in Parkinson Disease
October 3rd 2022Location, cost, and transportation were cited as important factors regarding adherence and satisfaction with community-based exercise programs among patients with Parkinson disease.
Read More
T&E Regimen, Consistent Adherence Important to Management of nAMD
October 2nd 2022Posters presented at the American Academy of Ophthalmology 2022 annual meeting show that the treat-and-extend (T&E) regimen was effective in managing neovascular age-related macular degeneration (nAMD), which makes adherence to treatment vital for long-term outcomes.
Read More
Dr Ravi Goel Discusses the Future of Technology in Ophthalmic Practice
October 1st 2022The ophthalmology practice of the future will need to manage patients more efficiently and that means incorporating more technology, said Ravi Goel, MD, spokesperson for the AAO and ophthalmologist at Regional Eye Associates in New Jersey.
Watch
Panel Reviews Health Inequities and Opportunities for Innovation Through Population Health Delivery
September 30th 2022A panel discussion at the 70th Annual Roy A. Bowers Pharmaceutical Conference addressed recent care delivery initiatives in New Jersey that aim to address health inequities and other population health concerns.
Read More
Dr Melissa O'Connor Reviews Considerations for Discharge in Home Health
September 30th 2022Melissa O'Connor, PhD, MBA, RN, FGSA, FAAN, endowed professor in Community and Home Health Nursing, M. Louise Fitzpatrick School of Nursing, Villanova University, and director, Gerontology Interest Group, discussed several factors for clinicians to consider in creating plans to discharge adults from skilled home health care.
Watch
Contributor: It’s Time to Talk About Paying Clinical Trial Participants More
September 30th 2022There is wide variation in the governance over research participant pay, and with rapid advances in technology enabling trial access, industry should step up and pay patients what they are worth, says Gunnar Esiason, a patient advocate living with cystic fibrosis.
Read More
Pediatric ESS Effective, Safe to Treat Chronic Sinusitis With Nasal Polyps
September 28th 2022With a high recurrence rate following surgery to treat chronic sinusitis with nasal polyps, authors set out to investigate the effectiveness and safety of endoscopic sinus surgery (ESS) in a pediatric patient population.
Read More
Potential for PHC Necessitates Pediatric Cardiology Care for Children With PAH
September 28th 2022Outcomes following right heart catheterization in a pediatric patient population were analyzed, with emphasis placed on risk of adverse outcomes following the procedure, especially the development of pulmonary hypertensive crisis (PHC).
Read More
Dr Paul Hahn Highlights Shifting Trends Among Retina Specialists
September 27th 2022There has been a sea change in how retina specialists treat retinal diseases, with a progressive shift toward more utilization of anti–vascular endothelial growth factor (VEGF), said Paul Hahn, MD, vitreoretinal surgeon at NJRetina.
Watch
Skin Biomarkers Found to Predict Development of Pediatric Atopic Dermatitis
September 26th 2022Significant alterations were observed in lipid levels and other skin biomarkers for infants who developed atopic dermatitis (AD) vs controls, with phytosphingosine associated with the highest AD prediction accuracy.
Read More
Perspectives on Nonmedical Switching and the COVID-19 Pandemic: A Narrative Review
This review describes the impact of nonmedical switching of biologic therapies on US patients and providers, with a focus on switching to in-class alternatives.
Read More
Dr Paul Forsberg: Ensuring Consistent, Clear Messaging Critical During Biosimilar Conversion
September 25th 2022When converting a patient to a biosimilar, having clear and consistent messaging will reduce confusion and prevent patients from having a lack of trust in the process, said Paul Forsberg, PharmD, director of pharmacy, Minnesota Oncology.
Watch